Back to ANRO
BlackRock, Inc. ANRO Position History
Alto Neuroscience, Inc. • Healthcare
Quarters held
22
Latest value
$816K
Q3 2026
Peak value
$40.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $73K |
| Q4 2025 | $4.5M |
| Q4 2025 | $6.2M |
| Q4 2025 | $114K |
| Q1 2026 | $93K |
| Q1 2026 | $7M |
| Q1 2026 | $7.8M |
| Q1 2026 | $164K |
| Q2 2026 | $294K |
| Q2 2026 | $2M |
| Q2 2026 | $1.6M |
| Q2 2026 | $33.5M |
| Q2 2026 | $18.4M |
| Q2 2026 | $187K |
| Q3 2026 | $527K |
| Q3 2026 | $6K |
| Q3 2026 | $2.3M |
| Q3 2026 | $1.8M |
| Q3 2026 | $40.8M |
| Q3 2026 | $22.9M |
| Q3 2026 | $446K |
| Q3 2026 | $816K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $816K | 31.9K | — | — |
| Q3 2026 | $446K | 17.5K | — | — |
| Q3 2026 | $22.9M | 897.1K | — | — |
| Q3 2026 | $40.8M | 1.60M | — | — |
| Q3 2026 | $1.8M | 71.0K | — | — |
| Q3 2026 | $2.3M | 88.7K | — | — |
| Q3 2026 | $6K | 236 | — | — |
| Q3 2026 | $527K | 20.6K | — | — |
| Q2 2026 | $187K | 7.1K | — | — |
| Q2 2026 | $18.4M | 695.7K | — | — |
| Q2 2026 | $33.5M | 1.27M | — | — |
| Q2 2026 | $1.6M | 59.1K | — | — |
| Q2 2026 | $2M | 77.3K | — | — |
| Q2 2026 | $294K | 11.2K | — | — |
| Q1 2026 | $164K | 7.3K | — | — |
| Q1 2026 | $7.8M | 345.2K | — | — |
| Q1 2026 | $7M | 309.5K | — | — |
| Q1 2026 | $93K | 4.1K | — | — |
| Q4 2025 | $114K | 6.4K | — | — |
| Q4 2025 | $6.2M | 345.7K | — | — |
| Q4 2025 | $4.5M | 251.7K | — | — |
| Q4 2025 | $73K | 4.1K | — | — |
Other funds holding ANRO
$97.8M
$94.7M
$83.4M
$71.9M
$69.5M
$61.2M